IceCure Medical Ltd (ICCM)
NASDAQ: ICCM
· Real-Time Price · USD
0.97
-0.02 (-2.02%)
At close: Jun 13, 2025, 3:58 PM
0.98
0.82%
After-hours: Jun 13, 2025, 05:40 PM EDT
-2.02% (1D)
| Bid | 0.95 |
| Market Cap | 54.99M |
| Revenue (ttm) | 3.28M |
| Net Income (ttm) | -15.29M |
| EPS (ttm) | -0.28 |
| PE Ratio (ttm) | -3.47 |
| Forward PE | -5.88 |
| Analyst | Buy |
| Ask | 1.03 |
| Volume | 205,864 |
| Avg. Volume (20D) | 263,944 |
| Open | 0.95 |
| Previous Close | 0.99 |
| Day's Range | 0.97 - 0.99 |
| 52-Week Range | 0.48 - 1.66 |
| Beta | 2.59 |
About ICCM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ICCM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ICCM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-15.54%
IceCure Medical shares are trading lower. The comp...
Unlock content with
Pro Subscription
7 months ago
+18.18%
IceCure Medical shares are trading higher after the company announced that a large number of public comments have been posted from key stakeholders ahead of the FDA Medical Device Advisory Committee Panel for marketing authorization of ProSens® cryoablation in early-stage low risk breast cancer.
